Help optimize biomanufacturing performance with a custom engineered host cell line
Partner with the right gene editing experts to aid your biotherapeutic development with custom editing of bioproduction cell lines that support your specific manufacturing needs for protein and viral vector therapeutics.
With over 10 years’ experience in gene editing for biotherapeutic manufacturing and >60 global regulatory filings, together we can help advance your biotherapeutic research program.
Benefit from:
- An advanced CRISPR-based platform that helps deliver cell line editing with precision and speed
- Built-in flexibility with established Revvity host cell lines (CHOSOURCE™ expression platform) or any other cell hosts provided by customers
- Capabilities in knock-in, knock-out and multiplex gene editing
- Various functional validation assays for engineered cell lines available on request
- Fully trackable documented history for all commercial cell lines, to support IND/CTA filings
Bioproduction cell line engineering service workflow
For research use only. Not for use in diagnostic procedure